Abstract
One of the main limitations for the use of synthetic vectors in gene therapy is their relatively low in vivo efficiency when compared with viral vectors. Here, we describe a pretreatment protocol with liposome-encapsulated clodronate in mice by which gene expression levels of a luciferase reporter gene could be increased up to nine-fold in the lung, after intravenous (i.v.) injection of glycerolipoplexes. Optimal results were obtained if mice were pretreated with liposome-encapsulated clodronate 1 day before injection of lipoplexes. The enhancement effect could be observed for lipoplexes prepared with different multivalent cationic glycerolipids. Most remarkably, polyplexes behaved in the opposite way. Liposome-encapsulated clodronate pretreatment strongly reduced reporter gene expression after i.v. injection of polyethylenimine-polyplexes (ExGen500).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wheeler CJ et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in the mouse lung Proc Natl Acad Sci 1996 93: 11454–11459
Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung Hum Gene Ther 1996 7: 1701–1717
Song YK, Liu F, Chu S, Liu D . Characterisation of cationic-liposome mediated gene transfer in vivo by intravenous administration Hum Gene Ther 1997 8: 1585–1594
Hara T, Tan Y, Huang L . In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector Proc Natl Acad Sci USA 1997 94: 14547–14552
Liu F, Qi H, Liu D . Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration Gene Therapy 1997 4: 517–523
Templeton NS et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression Nat Biotechnol 1997 15: 647–652
Li S, Huang L . In vivo gene transfer via intravenous administration of cationic lipid-protamine–DNA (LPD) complexes Gene Therapy 1997 4: 891–900
Barron LG, Meyer KB, Szoka FC . Effect of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid–DNA complexes Hum Gene Ther 1998 9: 315–323
Hong K, Zheng W, Baker A, Papahadjopoulos D . Stabilisation of cationic liposome–plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery FEBS Lett 1997 400: 233–237
Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery Nat Biotechnol 1997 15: 167–173
Mahato RI, Rolland A, Tomlinson E . Cationic lipid-based gene delivery systems: pharmaceutical perspectives Pharm Res 1997 14: 853–859
Lee RJ, Huang L . Lipidic vector systems for gene transfer Crit Rev Ther Drug Carrier Syst 1997 14: 173–206
Kabanov AV, Felgner PL, Seymour LW . Self-assembling Complexes for Gene Delivery John Wiley & Sons: Chichester 1998
Boletta A et al. Nonviral gene delivery to the rat kidney with polyethylenimine Hum Gene Ther 1997 8: 1243–1251
Boussif O et al. A novel, versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc Natl Acad Sci USA 1995 92: 7297–7303
Wu GY et al. Receptor-mediated gene delivery in vivo J Biol Chem 1991 266: 14338–14342
Demeneix BA et al. Delivery of polynucleotides with polyamine lipids and polymers Nucleosides Nucleotides 1997 16: 1121–1127
Abdallah B, Sachs L, Demeneix BA . Non-viral gene transfer: applications in developmental biology and gene therapy Biol Cell 1995 85: 1–7
Litzinger DC et al. Fate of cationic liposomes and their complex with oligonucleotide in vivo Biochim Biophys Acta 1996 1281: 139–149
van Rooijen N, Kors N, vd Ende M, Dijkstra CD . Depletion and repopulation of macrophages in spleen and liver after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate Cell Tissue Res 1990 260: 215–222
van Rooijen N, Sanders A . Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Meth 1994 174: 83–93
Plosker GL, Goa KL . Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease Drugs 1994 47: 945–982
Kuzmin AI, Finegold MJ, Eisensmith RC . Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo Gene Therapy 1997 4: 309–316
Wolff G et al. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ J Virol 1997 71: 624–629
Worgall S et al. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract Hum Gene Ther 1997 8: 1675–1684
McLean JW et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice Am J Physiol 1997; 273: H387-H404
Thurston G et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice J Clin Invest 1998 101: 1401–1413
Devine DV et al. Liposome-complement interactions in rat serum: implications for liposome survival studies Biochim Biophys Acta 1994 1191: 43–51
Plank C, Mechtler K, Szoka FC, Wagner E . Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery Hum Gene Ther 1996 7: 1437–1446
Zelphati O, Uyechi LS, Barron LG, Szoka FC . Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and their interactions with cells Biochim Biophys Acta 1998 1390: 119–133
Thepen T, van Rooijen N, Kraal G . Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice J Exp Med 1989 170: 499–509
Austyn JM, Gordon S . F4/80, a monoclonal antibody directed specifically against the mouse macrophage Eur J Immunol 1981 11: 805–815
Zanta MA, Boussif O, Adib A, Behr JP . In vitro gene delivery to hepatocytes with galactosylated polyethylenimine Bioconjug Chem 1997 8: 839–844
Luskey KL . Structure and expression of 3-hydroxy 3-methylglutaryl coenzyme A reductase Ann NY Acad Sci 1986 478: 249–254
Acknowledgements
We would like to acknowledge the excellent technical help of J Kintz, M de Meyer, H Schultz, F Mischler, D Elmlinger, C Mougin, V Nourtier, C Gerard and N Settelen; Dr B Cavallini and I Renardet for preparation of plasmid DNA. We thank Dr M Courtney for critical comments on the manuscript and M Autem for help with the statistical analysis. Clodronate was a gift from Boehringer Mannheim GmbH, Mannheim, Germany. We also thank Drs D Heissler and A Nazih (ULP Strasbourg) for the synthesis of cationic glycerolipids and Drs MA Zanta and JP Behr for providing plasmid pCMV-Luc.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schughart, K., Bischoff, R., Hadji, D. et al. Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice. Gene Ther 6, 448–453 (1999). https://doi.org/10.1038/sj.gt.3300826
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300826
Keywords
This article is cited by
-
Plasmid CpG Depletion Improves Degree and Duration of Tumor Gene Expression After Intravenous Administration of Polyplexes
Pharmaceutical Research (2008)
-
Multiple systemic expression of human interferon-β in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex
Gene Therapy (2000)
-
Cationic amphiphiles of both lipid and nonlipid nature in gene therapy
Russian Chemical Bulletin (2000)